Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

Malaria Journal

Volumn 10, Issue , 2011, Pages

  O'Connell, Kathryn A ^a   Gatakaa, Hellen ^a   Poyer, Stephen ^a   Njogu, Julius ^a   Evance, Illah ^a   Munroe, Erik ^a   Solomon, Tsione ^a   Goodman, Catherine ^b   Hanson, Kara ^b   Zinsou, Cyprien ^c   Akulayi, Louis ^d   Raharinjatovo, Jacky ^e   Arogundade, Ekundayo ^f   Buyungo, Peter ^g   Mpasela, Felton ^h   Adjibabi, Chérifatou ⁱ   Agbango, Jean ^j   Ramarosandratana, Benjamin ^k   Coker, Babajide ^l   Rubahika, Denis ^m   Hamainza, Busiku ⁿ   Chapman, Steven ^a   Shewchuk, Tanya ^a   Chavasse, Desmond ^a   more..

^a POPULATION SERVICES INTERNATIONAL   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Association Béninoise Pour le Marketing Social   (Benin)

^d Association de Santé Familiale   (Congo)

^e PSI/Madagascar   (Madagascar)

^f Key Population Community HIV AIDS Action and Response   (Nigeria)

^g PACE   (Uganda)

^h Society for Family Health   (Zambia)

ⁱ Programme National de Lutte Contre le Paludisme (PNLP)   (Benin)

^j National Malaria Control Programme   (Congo)

^k Programme National de Lutte Contre le Paludisme (PNLP Madagascar)   (Madagascar)

^l National Malaria Control Programme   (Nigeria)

^m MINISTRY OF HEALTH   (Uganda)

ⁿ National Malaria Control Centre   (Zambia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; CHLOROQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; ANTIMALARIAL AGENT; ARTEMISIN; ARTEMISININ DERIVATIVE; LACTONE;

BENIN; DEMOCRATIC REPUBLIC CONGO; DRUG COST; DRUG MARKETING; DRUG QUALITY; HEALTH CARE AVAILABILITY; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; MADAGASCAR; MALARIA; MONOTHERAPY; NIGERIA; ORGANIZATION AND MANAGEMENT; REVIEW; SOCIAL MARKETING; UGANDA; ZAMBIA; AFRICA; ARTICLE; COMMERCIAL PHENOMENA; DRUG COMBINATION; ECONOMICS; ENDEMIC DISEASE; STATISTICS;

AFRICA; ANTIMALARIALS; ARTEMISININS; COMMERCE; DRUG COMBINATIONS; ENDEMIC DISEASES; HUMANS; LACTONES; MALARIA; PRIVATE SECTOR; PUBLIC SECTOR;

EID: 80054996071     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-326     Document Type: Review

References (41)

1. World Health Organization, The African Summit on Roll Back Malaria, Abuja, Nigeria. Geneva 2000
2. RBM, Global Strategic Plan: Roll Back Malaria 2005-2015. Geneva 2005
3. World Health Organization, World Malaria Report 2009. Geneva 2009 http://www.who.int/malaria/world-malaria-report-2009/en/index.html
4. Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam. Kachur SP, Black C, Abdulla S, Goodman C, Malar J 2006 5 25 10.1186/1475-2875-5-25 16569252
5. Cost of increasing access to artemisinin combination therapy: the Cambodian experience. Yeung S, Damme WV, Socheat D, White NJ, Mills A, Malar J 2008 7 84 10.1186/1475-2875-7-84 18492245 (Pubitemid 351945028)
6. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Eastman RT, Fidock DA, Nat Rev Microbiol 2009 7 864 74 19881520
7. Availability and choice of antimalarials at medicine outlets in Ghana: the question of access to effective medicines for malaria control. Buabeng KO, Duwiejua M, Matowe LK, Smith F, Enlund H, Clin Pharmacol Ther 2008 84 613 619 10.1038/clpt.2008.130 18615006
8. Medicines for Malaria Venture, Understanding the Antimalarials Market: Uganda 2007-An overview of the supply side. Geneva 2008 http://www.mmv.org/ newsroom/publications/understanding-antimalarials-market-uganda-2007-overview- supply-side
9. Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW, Am J Trop Med Hyg 2009 80 737 738 19407116
10. Brands, costs and registration status of anti-malarial drugs in the Kenyan retail sector. Amin AA, Snow RW, Malar J 2005 4 36 10.1186/1475-2875-4-36 16042815 (Pubitemid 41192060)
11. Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi. Amuasi JH, Diap G, Blay-Nguah S, Boakye I, Karikari PE, Dismas B, Karenzo J, Nsabiyumva L, Louie KS, Kiechel JR, Malar J 2011 10 34 10.1186/1475-2875-10-34 21310057
12. The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets. Larson BA, Amin AA, Noor AM, Zurovac D, Snow RW, BMC Public Health 2006 6 314
13. Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature. Wafula FN, Goodman CA, Int J Qual Health Care 2010 22 316 323 10.1093/intqhc/mzq022 20430823
14. Anti-malarial market and policy surveys in sub-Saharan Africa. Diap G, Amuasi J, Boakye I, Sevcsik AM, Pecoul B, Malar J 2010 9 1 21144081
15. Obstacles to prompt and effective malaria treatment lead to low community-coverage in two rural districts of Tanzania. Hetzel MW, Obrist B, Lengeler C, Msechu JJ, Nathan R, Dillip A, Makemba AM, Mshana C, Schulze A, Mshinda H, BMC Public Health 2008 16 317
16. Poor knowledge on new malaria treatment guidelines among drug dispensers in private pharmacies in Tanzania: the need for involving the private sector in policy preparations and implementation. Minzi OM, Haule AF, East African J of Pub Health 2008 5 117
17. Concentration and drug prices in the retail marketfor malaria treatment in rural Tanzania. Goodman C, Kachurc SP, Abdullad S, Blolande P, Mills A, Health Econ 2009 18 727 742 10.1002/hec.1473 19301420
18. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets-a provider perspective. Alba S, Hetzel MW, Goodman C, Dillip A, Jafari L, Mshinda H, Lengeler C, Malar J 2010 9 164 10.1186/1475-2875-9-164 20550654
19. Estimating anti-malarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs). Kindermans JM, Vandenbergh D, Vreeke E, Olliaro P, D'Altilia JP, Malar J 2007 6 91 10.1186/1475-2875-6-91 17623092 (Pubitemid 47263420)
20. Sabot O, Yeung S, Pagnoni F, Gordon M, Petty N, Schmits K, Talisuna A, Distribution of Artemisinin- Based Combination Therapies through Private-Sector Channels Lessons from Four Country Case Studies. Washington, DC 2008
21. Universal access to malaria medicines: innovation in financing and delivery. Adeyi O, Atun R, Lancet 2010 376 1869 1871 10.1016/S0140-6736(10) 61189-0 20940074
22. ACTwatch: a project to study antimalarial markets in seven countries. Shewchuk S, O'Connell KA, Goodman C, Hanson K, Chapman D, Chavasse D
23. OANDA https://fxtrade.oanda.com/your-account/fxtrade/register/forex-demo- account/signup/why-oanda?xid=2227&cr-id=3309420362
24. International Monetary Fund, World Economic Database http://www.imf.org/ external/pubs/ft/weo/2011/01/weodata/index.aspx
25. National Malaria Control Programme, National Strategic Plan, Ministry of Health. Benin: 2006-2010
26. President's Malaria Initiative, Country Profiles, Benin http://www.fightingmalaria.gov/countries/profiles/benin.html
27. Cost is killing patients: subsidising effective antimalarials. Talisuna A, Grewal P, Rwakimari JB, Mukasa S, Jagoe G, Banerji J, Lancet 2009 374 1224 6 10.1016/S0140-6736(09)61767-0 19819377
28. A major transition in malaria treatment: the adoption and deployment of artemisinin based combination therapies. Bosman A, Mendis KN, Am J Trop Med Hyg 2007 77 193 197 18165492
29. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, Munroe E, Chapman S, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Shewchuk T, Chavasse D, O'Connell KA, Monitoring fever treatment behavior and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries
30. An assessment of dispensing practices in private pharmacies in Dar-es-Salaam, Tanzania. Kagashe GA, Minzi O, Matowe L, Int J Pharm Pract 2011 19 30 5 10.1111/j.2042-7174.2010.00075.x 21235657
31. Deficient supplies of drugs for life threatening diseases in an African community. Lufesi NN, Aursnes AM, BMC Health Services Research 2007 7 86 10.1186/1472-6963-7-86 17573958 (Pubitemid 47030152)
32. Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. Sabot OJ, Mwita A, Cohen JM, Ipuge Y, Gordon M, Bishop D, Odhiambo M, Ward L, Goodman C, PLoS One 2009 4 6857 10.1371/journal.pone.0006857 19724644
33. "Conquering malaria". 2006. Breman JG, Mills A, Snow RW, Mulligan JA, Lengeler C, Mendis K, Sharp B, Morel C, Marchesini P, White NJ, Steketee RW, Doumbo OK, Disease Control Priorities in Developing Countries New York: Oxford University Press, Jamison DT, Breman JG, Measham AR, Alleyne G, 2 2006 413 432
34. World Health Organization: Marketing of oral artemisinin-based monotherapy medicines. http://www.who.int/malaria/monotherapy-manufacturers.pdf
35. Oxfam, Blind Optimism London 2008 http://www.oxfam.org.uk/resources/ policy/health/downloads/bp125-blind-optimism-private-health-care.pdf
36. World Bank, Healthy Development: The World Bank Strategy for Health, Nutrition, and Population Results Washington DC 2007
37. Is private health care the answer to the health problems of the world's poor? Hanson K, Gilson L, Goodman C, Mills A, Smith R, Feachem R, Feachem NS, Koehlmoos TP, Kinlaw H, PLoS Med 2008 5 233 10.1371/journal.pmed.0050233 19067483
38. Focusing on quality patient care in the new global subsidy for malaria medicines. Moon S, Pérez Casas C, Kindermans JM, de Smet M, von Schoen-Angerer T, PLoS Med 2009 6 1000106 10.1371/journal.pmed.1000106 19621068
39. The impact of retail sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya-a cluster randomized controlled trial. Kangwana B, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, Pandit J, Fegan GW, Todd J, Brooker S, Snow RW, Goodman C, PLoS Med 2011 8 1000437 10.1371/journal.pmed.1000437 21655317
40. Case management of malaria fever in Cambodia: results from national anti-malarial outlet and household surveys. Littrell M, Gatakaa H, Phok S, Allen H, Yeung S, Chuor CM, Dysoley L, Socheat D, Spiers A, White C, Shewchuck T, Chavasse D, O'Connell KA
41. The ACTwatch Group. http://www.actwatch.info